These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


197 related items for PubMed ID: 37277324

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis.
    Shah SP, Twilla JD, Kemp L, Phelps GL, Reaves A.
    J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):201-207. PubMed ID: 30896312
    [Abstract] [Full Text] [Related]

  • 6. State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.
    Puri L, Nottage KA, Hankins JS, Anghelescu DL.
    Paediatr Drugs; 2018 Feb; 20(1):29-42. PubMed ID: 28853040
    [Abstract] [Full Text] [Related]

  • 7. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department.
    García-Morin M, López-Sangüos C, Vázquez P, Alvárez T, Marañón R, Huerta J, Cela E.
    Hemoglobin; 2016 Nov; 40(6):388-391. PubMed ID: 28361592
    [Abstract] [Full Text] [Related]

  • 8. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL, Krajewski JA, Babineau J, Tresgallo M, Schechter W, Saroyan JM, Kharbanda A.
    Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Validation of patient-reported vaso-occlusive crisis day as an endpoint in sickle cell disease studies.
    Coyne KS, Currie BM, Callaghan M, Wyrwich KW, Pease S, Baker CL, Arkin S, Pittman DD.
    Eur J Haematol; 2022 Sep; 109(3):226-237. PubMed ID: 35569114
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies.
    Dampier CD, Smith WR, Wager CG, Kim HY, Bell MC, Miller ST, Weiner DL, Minniti CP, Krishnamurti L, Ataga KI, Eckman JR, Hsu LL, McClish D, McKinlay SM, Molokie R, Osunkwo I, Smith-Whitley K, Telen MJ, Sickle Cell Disease Clinical Research Network (SCDCRN).
    Clin Trials; 2013 Apr; 10(2):319-31. PubMed ID: 23539110
    [Abstract] [Full Text] [Related]

  • 14. Patient-Controlled Analgesia vs Intravenous Push Hydromorphone for Pain Management of Vaso-Occlusive Crisis Associated With Sickle Cell Disease.
    Russo K, Chhunchha P.
    J Pain Palliat Care Pharmacother; 2023 Jun; 37(2):116-122. PubMed ID: 36701332
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regional anesthesia for sickle cell disease vaso-occlusive crisis: A single-center case series.
    Karsenty C, Tubman VN, Liu CJ, Fasipe T, Wyatt KEK.
    Pediatr Blood Cancer; 2022 Jun; 69(6):e29695. PubMed ID: 35373913
    [Abstract] [Full Text] [Related]

  • 17. Association between Vaso-occlusive Crises and Opioid Prescriptions among Patients with Sickle Cell Disease: A Retrospective Claims-based Study.
    Kang HA, Barner JC, Richards KM, Bhor M, Paulose J, Kutlar A.
    J Health Econ Outcomes Res; 2020 Jun; 7(1):94-101. PubMed ID: 32685602
    [Abstract] [Full Text] [Related]

  • 18. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.
    van Beers EJ, van Tuijn CF, Nieuwkerk PT, Friederich PW, Vranken JH, Biemond BJ.
    Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790
    [Abstract] [Full Text] [Related]

  • 19. Early Initiation of Sub-Anesthetic Ketamine Infusion in Adults with Vaso-Occlusive Crises Is Associated with Greater Reduction in Sickle Cell Pain Intensity: A Single Center's Experience.
    Kenney MO, Becerra B, Mallikarjunan A, Shah N, Smith WR.
    Pain Med; 2022 Dec 01; 23(12):2042-2049. PubMed ID: 35708641
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.